Loading
The Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences was established in 1999 to honor scientists who have tirelessly pursued distinctive medical research that serves the interests of humanity. In this regard, the Award recognizes excellence through the greatly diversified international, regional and local awards. These efforts have paid off well, as two of the Grand Hamdan Award winners were awarded the Nobel Prize in Physiology in 2010 and 2020; SIR ROBERT G EDWARDS & DR. HARVEY J ALTER.
Today, we are organizing this new series of virtual activities to revisit the relevant Awards topics, to examine the scientific advances in each field, and to explore the winners’ new interests in the rapidly evolving scientific world.
This webinar will host Prof Sanford Markowitz, the Markowitz-Ingalls Professors of Cancer Genetics and Distinguished University Professor at Case Western Reserve University- United States of America. He is the winner of the Hamdan Award for Medical Research Excellence in 2015-2016 for Colon Disorders.
Markowitz awards include being the recipient of: an NCI Outstanding Investigator award, the Hamdan Award for Medical Research Excellence, and a Scholar Innovator Award of the Harrington Discovery Institute. He has served on scientific advisory boards at numerous institutions including the National Cancer Institute, the National Colon Cancer Research Alliance, the Dana Farber/Harvard Cancer Center, the University of Pennsylvania Abramson Cancer Center, and the Memorial Sloan-Kettering Cancer Center.
Professors of Cancer Genetics and Distinguished University Professor at Case Western Reserve University - USA
Winner of the Hamdan Award for Medical Research Excellence in 2015-2016.
Sanford Markowitz, M.D., Ph.D., is a medical oncologist and cancer researcher and is the Markowitz-Ingalls Professors of Cancer Genetics and Distinguished University Professor at Case Western Reserve University and medical oncologist at University Hospitals Seidman Cancer Center.
Markowitz did undergraduate work at Harvard College, took M.D. and Ph.D. degrees at Yale School of Medicine, performed internship and residency in internal medicine at University of Chicago, and medical oncology fellowship at the National Cancer Institute.
He is recognized for fundamental genetic studies in gastrointestinal cancers and development of molecular tests for early cancer detection. Markowitz is a founder of Rodeo Therapeutics, for developing small molecule therapies for tissue regeneration. He is also a founder of Lucid Diagnostics and is a coinventor of Lucid’s EsoGuard and EsoCheck technology.
Markowitz is an alumnus investigator of the Howard Hughes Medical Institute and is the current Principal Investigator of the NCI - Case GI Cancers Specialized Program of Research Excellence.
Markowitz awards include being the recipient of: an NCI Outstanding Investigator award, the Hamdan Award for Medical Research Excellence, and a Scholar Innovator Award of the Harrington Discovery Institute. He has served on scientific advisory boards at numerous institutions including the National Cancer Institute, the National Colon Cancer Research Alliance, the Dana Farber/Harvard Cancer Center, the University of Pennsylvania Abramson Cancer Center, and the Memorial Sloan-Kettering Cancer Center.
Chairman/CEO – Medrise Medical Center FZ LLC
Member of the Board of Directors -Dubai Healthcare City Authority
ADNAN ABUHAMMOUR, MD, MsC, FACG
Dr Abuhammour is a highly qualified Gastroenterologist,and specialized in interventional Endoscopies. His main interest in addition to clinical research includes management of obesity (IGB) acid dyspepsia, inflammatory bowel disease, Video Capsule Endoscopy (VCE), viral hepatitis and non-surgical treatment of hemorrhoids.
Dr Abuhammour obtained his MBBS (with honor) from the University of Jordan, in 1984. Then he completed his internal medicine residency and obtained his Master degree in internal medicine (with honor) from the University of Jordan in 1987.
Dr Abuhammour is American Board certified in internal medicine and gastroenterology. He has done his residency in internal medicine and fellowship in Gastroenterology at the University of Illinois’ in Chicago. In addition he has completed one year of fellowship in advanced therapeutic endoscopy at the same University in USA.
On moving to Dubai in 1997, Dr Abuhammour was appointed as chairman of the department of medicine at the American Hospital until 2005. In 2006, he established the “Abuhammour Medical Center” at Dubai Health Care City, recently it renamed to Medrise Medical Center Fz LLC.
He is the immediate past President of the Emirates Medical Association Division of Gastroenterology (EMAGI).
Dr Abuhammour has published many articles, medical reviews, editorials and book chapters. He has organized many regional medical conferences and he received a variety of honors and recognition awards from different medical and gastroenterology societies.
